2023 RNA Editing Gordon Research Conference and Gordon Research Seminar
2023 RNA Editing Gordon Research Conference and Gordon Research Seminar
批准号:
10683612
负责人:
PETER A. BEAL
金额:
$0.95万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-03-15 至 2024-03-14
关键词:
AsiaAutoimmune DiseasesBiochemistryBiological ModelsBiological ProcessCanadaCellular biologyChemicalsCognitionCollaborationsCytosineDNADNA Modification ProcessDataDeaminaseDedicationsDefectDetectionDevelopmentEngineeringEnzymesEpigenetic ProcessEuropeFacultyFemaleFosteringGene ExpressionGenesGenetic DiseasesGoalsHealthHealth SciencesHourHumanIndustryInternationalKnowledgeMalignant NeoplasmsMentorshipModificationNatural ImmunityNotificationNucleic AcidsNucleosidesPostdoctoral FellowProtein BiosynthesisRNARNA EditingRenaissanceResearchResearch PersonnelRestSaskatchewanScienceScientistStudent SelectionsSurveysTechniquesTexasTherapeuticTransfer RNAUniversitiesUracilWomanadaptive immunitybasebase editorbiological systemscareerepitranscriptomicsgender equitygenome editinggraduate studenthuman diseasemeetingsnext generationnucleobaseposterssymposium
中文摘要
项目摘要
GRC on RNA editing是致力于核酸修饰的首要国际会议。的
2023年会议的副标题是:“RNA/DNA编辑和跨生物系统的epitranscriptomics”。修改
与DNA和RNA中常见核苷的相互作用已被人们所知多年。但最近的
检测这些物质的分析技术的进步,沿着对广泛影响的更深入了解,
这些变化对基本生物过程,包括人类疾病的影响,
复兴在他们的研究。事实上,我们现在知道,核酸修饰在各种细胞中是常见的。
天然存在的核酸和影响基因表达,蛋白质合成,认知,先天和
适应性免疫、自身免疫性疾病和癌症。此外,一些研究实验室已经重新利用
天然编辑RNA或修饰DNA碱基以进行靶向基因组编辑的酶。这次会议将带来
将具有不同专业知识的不同科学家群体聚集在一起,共同目标是分享想法,
这些方法可以促进我们对核酸修饰的许多方面的理解。这
会议有三个具体目标。首先,我们将支持下一代科学技术的发展,
领导人的人选信号实现这一目标的关键是支持随之而来的戈登研究研讨会(GRS)。在
在全球研究大会前两天,将举行一次全球研究大会,重点是交换研究数据,
编辑和修改领域的研究生和博士后的想法。我们的第二个具体目标是
促进DNA和RNA编辑和修饰方面的知识交流。在为期五天的GRC中,
每天下午大约四个小时的网络,有四个海报会议,46个发言者和6个
演讲者从涵盖DNA和RNA编辑研究各个方面的摘要中选出,以促进
跨学科和协作互动。我们的第三个目标是将学术研究人员与
行业的利益相关者。基因编辑公司和生物医学科学公司的代表,
编辑/修改焦点将参加2023年会议。这种互动将促进合作
与公司或其他实验室,可以采取基本的健康相关的研究,以一个新的发展水平,
治疗遗传疾病。
英文摘要
Project Summary
The GRC on RNA editing is the premier international meeting dedicated to nucleic acid modifications. The
2023 meeting is subtitled: “RNA/DNA editing and epitranscriptomics across biological systems”. Modifications
to the common nucleosides found in DNA and RNA have been known for many years. However, recent
advances in analytical techniques for their detection, along with a deeper understanding of the broad impact
these modifications have on fundamental biological processes, including human disease, have caused a
renaissance in their study. Indeed, we now know that nucleic acid modifications are common in various
naturally occurring nucleic acids and influence gene expression, protein synthesis, cognition, innate and
adaptive immunity, autoimmune disease and cancer. Furthermore, several research labs have repurposed
enzymes that naturally edit RNA or modify DNA bases for targeted genome editing. This meeting will bring
together a diverse group of scientists with varying expertise with the common goal of sharing ideas and
approaches that can advance our understanding of the many facets of nucleic acid modifications. This
conference has three specific aims. First, we will support the development of the next generation of scientific
leaders. Key to achieving this aim is supporting the accompanying Gordon Research Seminar (GRS). In the
two days preceding the GRC, a GRS will take place that is focused on the exchange of research data and
ideas among graduate students and post-docs in the editing and modification field. Our second specific aim is
to facilitate knowledge exchange on DNA and RNA editing and modification. During the five day GRC, there is
approximately four hours in each afternoon for networking, there are four poster sessions, 46 speakers and 6
speakers selected from abstracts covering all aspects of DNA and RNA editing research to foster
interdisciplinary and collaborative interactions. Our third aim is to connect academic researchers to
stakeholders in industry. Representatives of gene editing companies and biomedical science companies with
an editing/modification focus will participate in the 2023 conference. This interaction will facilitate collaboration
with companies or other labs that can take basic health related research to the next level of developing
treatments for genetic diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
UC Davis Chemical Biology Program
-
批准号:10205728
-
项目类别:
-
资助金额:$24.55万
-
财政年份:2021
-
负责人:PETER A. BEAL
-
依托单位:
Defining and Controlling Protein-RNA interactions in editing and interference pathways
-
批准号:10610334
-
项目类别:
-
资助金额:$54.37万
-
财政年份:2021
-
负责人:PETER A. BEAL
-
依托单位:
UC Davis Chemical Biology Program
-
批准号:10618869
-
项目类别:
-
资助金额:$27.13万
-
财政年份:2021
-
负责人:PETER A. BEAL
-
依托单位:
Defining and Controlling Protein-RNA interactions in editing and interference pathways
-
批准号:10206748
-
项目类别:
-
资助金额:$34.22万
-
财政年份:2021
-
负责人:PETER A. BEAL
-
依托单位:
Supplement: Defining and Controlling Protein-RNA interactions in editing and interference pathways
-
批准号:10807900
-
项目类别:
-
资助金额:$1.09万
-
财政年份:2021
-
负责人:PETER A. BEAL
-
依托单位:
Defining and Controlling Protein-RNA interactions in editing and interference pathways
-
批准号:10390419
-
项目类别:
-
资助金额:$54.78万
-
财政年份:2021
-
负责人:PETER A. BEAL
-
依托单位:
UC Davis Chemical Biology Program
-
批准号:10409717
-
项目类别:
-
资助金额:$26.52万
-
财政年份:2021
-
负责人:PETER A. BEAL
-
依托单位:
UC Davis Training Program in Chemical Biology
-
批准号:9306883
-
项目类别:
-
资助金额:$15.59万
-
财政年份:2015
-
负责人:PETER A. BEAL
-
依托单位:
Nucleobase analogs for next generation siRNAs
-
批准号:8634117
-
项目类别:
-
资助金额:$30.54万
-
财政年份:2007
-
负责人:PETER A. BEAL
-
依托单位:
Chemical Modifications of siRNA Bases to Control Off-target Effects
-
批准号:7390349
-
项目类别:
-
资助金额:$25.75万
-
财政年份:2007
-
负责人:PETER A. BEAL
-
依托单位:
Chemical Modifications of siRNA Bases to Control Off-target Effects
-
批准号:7790635
-
项目类别:
-
资助金额:$25.46万
-
财政年份:2007
-
负责人:PETER A. BEAL
-
依托单位:
Nucleobase analogs for next generation siRNAs
-
批准号:9043104
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2007
-
负责人:PETER A. BEAL
-
依托单位:
Nucleobase analogs for next generation siRNAs
-
批准号:9707519
-
项目类别:
-
资助金额:$3.22万
-
财政年份:2007
-
负责人:PETER A. BEAL
-
依托单位:
Chemical Modifications of siRNA Bases to Control Off-target Effects
-
批准号:7171734
-
项目类别:
-
资助金额:$24.66万
-
财政年份:2007
-
负责人:PETER A. BEAL
-
依托单位:
Nucleobase analog for the next generation siRNa
-
批准号:9381652
-
项目类别:
-
资助金额:$32.19万
-
财政年份:2007
-
负责人:PETER A. BEAL
-
依托单位:
Nucleobase analogs for next generation siRNAs
-
批准号:8514236
-
项目类别:
-
资助金额:$30.77万
-
财政年份:2007
-
负责人:PETER A. BEAL
-
依托单位:
Chemical Modifications of siRNA Bases to Control Off-target Effects
-
批准号:7591711
-
项目类别:
-
资助金额:$25.74万
-
财政年份:2007
-
负责人:PETER A. BEAL
-
依托单位:
RNA-SPECIFIC LIGANDS: AN APPROACH TO NEW ANTIVIRALS
-
批准号:6488786
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2001
-
负责人:PETER A. BEAL
-
依托单位:
RNA-SPECIFIC LIGANDS: AN APPROACH TO NEW ANTIVIRALS
-
批准号:6626410
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2001
-
负责人:PETER A. BEAL
-
依托单位:
MOLECULAR MECHANISM OF RNA EDITING ADENOSINE DEAMINASE
-
批准号:6636429
-
项目类别:
-
资助金额:$15.56万
-
财政年份:2001
-
负责人:PETER A. BEAL
-
依托单位:
国内基金
海外基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
-
批准号:31171277
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:Christine Nardini
-
依托单位: